![Omar Khwaja](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Omar Khwaja
Directeur Technique/Scientifique/R&D chez
Spinal Muscular Atrophy Foundation
Profil
Omar Khwaja currently works at Korro Bio, Inc. (Old), as Director, The Royal College of Physicians, as Member from 1999, Spinal Muscular Atrophy Foundation, as Chief Medical Officer, The Royal College of Paediatrics & Child Health, as Member, and VectivBio Holding AG, as Chief Medical Officer from 2021.
Dr. Khwaja also formerly worked at The Children's Hospital Corp., as Director-Clinical Neurogenetics Program, F.
Hoffmann-La Roche Ltd., as Global Head-Rare Diseases from 2013 to 2019, Roche Pharma (Schweiz) AG, as Global Head-Rare Diseases from 2012 to 2019, and Voyager Therapeutics, Inc., as Chief Medical Officer, Head-Research & Development from 2019 to 2021.
Dr. Khwaja received his doctorate degree from the University of Cambridge.
Postes actifs de Omar Khwaja
| Sociétés | Poste | Début |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1999 |
The Royal College of Paediatrics & Child Health
 The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Directeur/Membre du Conseil | - |
Spinal Muscular Atrophy Foundation
 Spinal Muscular Atrophy Foundation Miscellaneous Commercial ServicesCommercial Services Provides spinal muscular atrophy healthcare services | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Omar Khwaja
| Sociétés | Poste | Fin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/05/2021 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/04/2019 |
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 01/04/2019 |
| VECTIVBIO HOLDING AG | Directeur Technique/Scientifique/R&D | - |
The Children's Hospital Corp.
 The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Corporate Officer/Principal | - |
Formation de Omar Khwaja
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Health Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Spinal Muscular Atrophy Foundation
Spinal Muscular Atrophy Foundation Miscellaneous Commercial ServicesCommercial Services Provides spinal muscular atrophy healthcare services | Commercial Services |
The Royal College of Paediatrics & Child Health
The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
